Alternate Day Buprenorphine Administration, Phase XI - 16

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to evaluate open buprenorphine dosing with dose choice after open exposure.

Key facts

Study ID

NCT00000234

Run by

University of Vermont

People needed

0

Last updated by the study team

2016-05-06

Who can join

Age: 25 and older, up to 51. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.